1Surveillance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia. *Corresponding Author: Elizabeth J. Schafer, Surveillance ...
Search for other works by this author on: ...
1Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. *Corresponding Author: Christopher G. Cann, Department of Hematology and Oncology, Fox Chase Cancer Center, ...
1Inocras Inc., San Diego, California. 2Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. *Corresponding Author: Young ...
1Department of Biological Sciences, New York City College of Technology, City University of New York, Brooklyn, New York. 2Biology and Computer PhD Programs, The CUNY Graduate Center, City University ...
Revolution Medicines, Redwood City, CA.
Abstract. T-cell engagers (TCEs) display increasing potential as an immunotherapeutic treatment for both hematologic and solid cancers. These multi-specific antibody-based therapeutics consist of a ...
Cancer Res (2025) 85 (8_Supplement_1): 6376.
University Health Network, Toronto, Ontario, Canada.
Search for other works by this author on: ...
1Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. 2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback